Kidney function tests, or renal tests have several categories, which
includes concentration and dilution tests, clearance tests (provides
an assessment of the filtration rate of the glomeruli, the principal
filtering structures of the kidneys and whole renal blood
flow),visual and physical examination of the urine, and determination
of the concentration of numerous substances in the urine, notably
glucose, phosphate, sodium, amino acids, and potassium, to help
detect possible impairment of the specific kidney functions generally
involved with their reabsorption.
It was stated by the World Health Organization in the past that more
than 1.4 mn patients per year undergo renal replacement therapy.
Additionally, the organization stated that this number is increasing
by nearly 8% every year. At the same time, the global kidney function
tests market may also be hampered by the growing number of
restrictions related to healthcare expenditure and stringent
regulatory pressure regarding the use of certain methods in kidney
tests.
Globally, the factors driving the growth of kidney function tests
market include increasing incidences and prevalence of chronic kidney
disease worldwide, aging population,high incidence rate of renal
fibrosis, and increasing number of individuals suffering from
diabetes. Also, other complications such as high blood pressure is
contributing towards the increasing incidence rate and prevalence of
chronic kidney disease worldwide.Demand for kidney function tests is
mainly driven by the presence of a large patient population suffering
from renal disorders. According to the WHO, there are more than 1.4
million people worldwide, who undergo renal replacement therapy every
year with the incidence rate of chronic kidney disease growing by
approximately 8% annually.However, increase in overall stringent
regulatory approvals and healthcare expenditure are some of the
market-restraining factors that might hamper the growth of the kidney
function tests market in future.
Importance of Kidney Function Tests: https://goo.gl/K8SfJ6
From a geographical perspective, the global kidney function tests
market is led by North America, followed by Europe. Both regions have
advanced in the global kidney function tests market owing to the
higher prevalence of kidney-related issues and the presence of a
fully established healthcare industry, complete with the latest
infrastructure. This applies to the U.S. more than other countries.
Some of the key categories in the global kidney function tests market
are dilution and concentration tests, physical and visual examination
of urine, and clearance tests. Apart from these, another common form
of renal tests includes the assessment of urine to separate various
minerals and other substances, such as sodium, phosphate, glucose,
potassium, and amino acids. The key players in the global kidney
function tests market are Pfizer Inc., ManRos Therapeutics, Endocyte,
Inc., IC-Meditech, Plexxikon Inc., Eli Lilly and Company, Ipsen S.A.,
Kadmon Corporation, LLC, Otsuka Holdings Co., Ltd., Discovery Biomed,
Inc., Baxter International Inc., Galectin Therapeutics, Inc., and F.
Hoffmann-La Roche Ltd.
No comments:
Post a Comment